10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,791 | -25.8% | 1,304 | +0.4% | 0.00% | – |
| Q2 2023 | $72,537 | +18.0% | 1,299 | +17.9% | 0.00% | – |
| Q1 2023 | $61,481 | +18.5% | 1,102 | -22.6% | 0.00% | – |
| Q4 2022 | $51,890 | -16.3% | 1,424 | -35.0% | 0.00% | – |
| Q3 2022 | $62,000 | -25.3% | 2,192 | +19.3% | 0.00% | – |
| Q2 2022 | $83,000 | -46.5% | 1,838 | -10.2% | 0.00% | – |
| Q1 2022 | $155,000 | +278.0% | 2,046 | +617.9% | 0.00% | – |
| Q4 2021 | $41,000 | +78.3% | 285 | +70.7% | 0.00% | – |
| Q3 2021 | $23,000 | -50.0% | 167 | -28.0% | 0.00% | – |
| Q2 2021 | $46,000 | +12.2% | 232 | +4.0% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 223 | +21.2% | 0.00% | – |
| Q4 2020 | $25,000 | +257.1% | 184 | +201.6% | 0.00% | – |
| Q3 2020 | $7,000 | +75.0% | 61 | +24.5% | 0.00% | – |
| Q2 2020 | $4,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |